Sep 14, 2021 / 03:45PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Great, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. Very pleased to have Kodiak with us here for the next session. Before we get started, I just need to read a disclosure statement.
Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/research disclosures. And pleased to have with us the whole team. So we have Victor Perlroth, the CEO; Jason Ehrlich, who runs Medical; and John Borgeson, who is the CFO. So thanks for being here. Very nice to have you.
Questions and Answers:
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive DirectorVictor, I thought maybe to start off, you obviously have sort of your first major of your clinical readouts coming up here with DAZZLE. So maybe a good place to start off is just remind people about the
Trustpilot
